study in non-diet-controlled women could be explained by the homogeneity of data in a higher number of participants.
We applied the index of heterogeneity (IH) in the whole set of data, and values obtained were clearly lower than the critical value 1.45 [12] , indicating homogeneity between within-subject variances. However, observation of the individual CV i revealed that some volunteers showed discrepant values compared with the global set of data. The Levene test was therefore applied and two individuals subseqently had to be ruled out. Thus, IH is not applicable in our set of data to establish homogeneity of variances.
II is considered to be the key for determining the practical utility of population-based reference ranges. If Ͻ0. 6 , the use of a reference interval is of little value for diagnostic purposes. If it is Ͼ1.4, then the reference interval is valuable [3] . II for GPX was 0.45, suggesting that it has little value as a diagnostic or screening tool. The differences in SOD II between sexes are principally related to the differences in SOD between-subject variation. At present, possible causes (influence of life-style or hormonal status) for these sex differences remain unknown.
To our knowledge, this is the first report on the biological variation of GPX in whole blood and SOD in erythrocytes. Data obtained from the biological variation of these enzymes support SOD in erythrocytes as the scavenger enzyme of choice for diagnosis of an alteration in antioxidant status in a pathological situation, as well as for screening in population studies. In view of its strong individuality and smaller critical differences compared with SOD, GPX determination in total blood would be useful for monitoring antioxidant status in pathological situations and changes in life-style such as diet or exercise. Improvement in measurement of GPX in blood is required to achieve the analytical goal established in this work.
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Measuring Nitrous Oxide in Exhaled Air by Gas Chromatography and Infrared Photoacoustic Spectrometry,
Takahiro Mitsui, 1 * Miharu Miyamura, 1 Aritaka Matsunami, 2 Kuniyuki Kitagawa, 2 and Norio Arai 2 ( 1 Res. Center of Health, Physical Fitness, and Sports, 2 Res. Center for Advanced Energy Conversion, Nagoya Univ., Furocho, Chikusaku, Nagoya, 464 -01, Japan; *author for correspondence: fax 81-52-789-3957, e-mail g960305d@sunspot. eds.ecip.nagoya-.ac.jp) Nitrous oxide (N 2 O) is a relatively stable compound, present at ϳ310 nL/L in the atmosphere. It is produced predominantly by microbial reduction of nitrate (NO 3 Ϫ ). This process, called denitrification, is the conversion of nitrate to gaseous nitrogen compounds, resulting in a product of nitrogen (N 2 ) or nitrous oxide under most conditions. Many kinds of denitrifying bacteria have been isolated from the human oral cavity, upper respiratory tract, and alimentary tract (e.g.) [1] [2] [3] [4] , including pathogens of Pseudomonas, Neisseria, and Campylobacter. Taking these studies into consideration, it is proper to assume that the concentrations of N 2 O in exhaled air exceed those in the atmosphere, although no studies have been published related to N 2 O in exhaled air. The purpose of this study is to establish an analytical method for detection of N 2 O in exhaled air by using gas chromatography (GC) and infrared-photoacoustic spectrometry (IR-PAS) [5] .
Exhaled air samples were collected from 15 healthy subjects, ages 20 -60 years. Each subject was fully informed of the experimental procedures before giving consent. Samples were collected with a commercially available breath collection system (a 750-mL gas sampler from Quintron, Milwaukee, WI). The exhalation procedure was as follows: Subjects were to inhale deeply but not to maximum capacity, hold the inhalation for ϳ5 s, and then exhale into the sampling bag. This procedure was repeated twice for all subjects. The protocol was approved by the Human Research Committee of the Research Center of Health, Physical Fitness, and Sports of Nagoya University.
The exhaled air sample was analyzed within 90 min of collection, because preliminary studies showed that leakage from the sampling bags was negligible over a 2-h period. Emission of N 2 O was taken as the difference in the concentration between the sample and the room air.
A gas chromatograph (Type GC-14BPE; Shimadzu) equipped with an autosampler, PoraPak (Q 80/100 mesh 1.0 m) columns, and a 63 Ni electron capture detector was used for the GC determinations of N 2 O concentrations. Methane, at 48. 5 mL/L in argon, was used as a carrier gas at a flow rate of 40 mL/min. The oven, columns, and detector temperatures were regulated at 60°C, 100°C, and 300°C, respectively. Calibration was with a gas of 3.1 L/L N 2 O in nitrogen (Nihon Sanso Co., Japan).
A MultiGas Monitor (Type 1302; Brü el & Kjaer, Denmark) equipped with an optical filter (UA0985, 2215 cm Ϫ1 ) was also used to determine N 2 O concentrations. The high humidity and carbon dioxide content (ϳ40 mL/L) in exhaled air posed a problem, because these interfered with infrared absorption of N 2 O. To remove this interference, sample gas was passed though a 5 cm ϫ 30 cm pipe containing 2-mm-diameter soda lime granules and a 5 cm ϫ 5 cm pipe containing 2-4-mm-diameter alumina granules in series before the analyzer. The calibration curve was constructed from analyses of pure nitrogen gas (grade S), the calibration gas (at 3.1 and 10.5 L/L), and various dilutions of these (final concentrations 1.1, 1.7, 2.1, and 5.3 L/L). The calibration curve shown in Fig. 1 (top) reveals good linearity for this range.
We found N 2 O in exhaled air from all subjects, at concentrations ranging from 60 to 890 nL/L by IR-PAS and from 30 to 730 nL/L by GC. Fig. 1 (bottom) shows the highly linear relationship between the values found by GC and IR-PAS (r ϭ 0.985, P Ͻ0.001) and a systematic error of ϳ10%. A possible cause of this difference is the slight absorption of N 2 O in the CO 2 /H 2 O trap. N 2 O is usually analyzed by GC with electron capture detection for analyses in the range of ppb (nL/L). Because N 2 O has Ͼ200 potent infrared absorption bands compared with CO 2 , one can detect such a low concentration of N 2 O by IR-PAS with almost the same accuracy as GC. The analytical time required for one sample by GC is ϳ12 min, whereas IR-PAS takes Ͻ2 min. In addition, a gas chromatograph equipped with an electron capture detector contains radioisotope ( 63 Ni), so the use of the apparatus is restricted for space. For these reasons, the IR-PAS device is practical enough for measuring N 2 O at concentrations in the range of Ͻ1 L/L in exhaled air if used with a suitable trap for CO 2 /H 2 O. Aldosterone, a steroid hormone secreted by the adrenal cortex, is important in the overall control of sodium and potassium balance. Abnormalities in aldosterone concentrations are seen in a variety of clinical conditions. Overproduction (hyperaldosteronism) may result both from a primary cause such as adrenal adenoma [1] or a secondary cause, e.g., stimulation by increased renin release [2] . Underproduction of the hormone is seen in such diseases as Addison disease [3] .
Many methods for measurement of plasma aldosterone have been based on the extraction method of James and Wilson [4] . However, technical progress has enabled the production of direct kit methods for measuring plasma aldosterone. Previous studies [5, 6] have demonstrated that direct methods gave anomalous results in certain circumstances, possibly because of the presence of polar metabolites. The purpose of the current study was to compare a direct method with an existing extraction method for measuring aldosterone-first, in a large number of samples from clinical sources, and second, after physiological alterations of sodium intake.
Plasma was obtained in the morning from 89 individuals after they had sat for 5-10 min: 40 patients with essential hypertension, average age 52 years (range 25-80 years; 21 men, 19 women); 28 presumed healthy volunteers, average age 45 years (range 24 -77 years; 19 men, 9 women); 17 patients with chronic renal failure (serum creatinine 349 Ϯ 32.2; range 189 -535 mol/L), average age 59 years (range 29 -83 years; 9 men, 8 women); a 42-year-old woman with a pheochromocytoma; 2 patients with Conn syndrome (a 37-year-old woman and a 35year-old man); and a 75-year-old woman with persistent hypertension and hypokalemia. Except for the chronic renal failure patients, none of the subjects had any sign of renal failure as determined by serum creatinine values (all Ͻ110 mol/L). In addition, two or three quality-control pools were analyzed in duplicate in each assay run.
We also determined the effect of sodium alteration on the measurement of plasma aldosterone concentrations in 8 hypertensive individuals (4 women, 4 men). Measurements were made after 1 month on a low-sodium diet and 1 month on a high-sodium diet in a double-blind, crossedover, randomized designed study.
Blood samples (10 mL) for the plasma aldosterone determinations were obtained from a subcutaneous vein in the forearm; collected into lithium-heparin tubes, the samples were immediately centrifuged at 1200g for 15 min at 4°C. The plasma was removed and stored at Ϫ20°C until assay. Blood was also taken for routine biochemical determinations. Urine samples (24 h) were collected for the measurement of sodium and creatinine. Blood pressure recordings were made with an ultrasound sphygmomanometer (Arteriosonde; Roche). Ethical approval was obtained from our institution.
The extraction-based method for RIA of plasma aldosterone was based on that of James and Wilson [4] . In brief, plasma samples (0.5 mL) were extracted with 10 mL of dichloromethane (BDH/Merck; AnalaR) to which had been added [ 3 H]aldosterone (Radiochemical Centre, Amersham), 1000 counts/min, to assess the recovery of the process for each sample. The aqueous phase was dried under air and the extracts were reconstituted in 500 L of phosphate-buffered saline (PBS; NaH 2 PO 4 ⅐ 2H 2 O 7.5 mmol/L, anhydrous Na 2 HPO 4 32.4 mmol/L, NaCl 103 mmol/L, sodium azide 15.4 mmol/L, bovine serum albumin 2 g/L). The reconstituted samples were then assayed by RIA, 100-L samples being placed, in duplicate, into assay tubes. Additionally, 100 L of sample was placed into scintillation vials to which was added 4.5 mL of scintillation fluid (Ultima-gold; Packard) to assess recovery. To the assay tubes was added 100 L of diluted antiserum (obtained from St. Mary's Hospital, Paddington, UK) and 100 L of 125 I-labeled aldosterone (Amersham) that had been diluted in PBS to 2000 counts/min. The maximum binding was 76.0% Ϯ 0.9% (n ϭ 85). A 9-point calibration curve covering the range 0 -160 pg/ tube (0 -4440 pmol/L) was prepared from dilutions of aldosterone (Sigma) in PBS. The effective limit of detection of the assay was given as equivalent to the lowestconcentration calibrator [1.25 pg/tube (35 pmol/L)]. The bound and unbound fractions were separated by adding 1 mL of cold dextran-coated charcoal [250 mg of activated charcoal (Sigma) and 25 mg of dextran T-70 (Pharmacia) in 100 mL of PBS] to the tubes. After 5 min the samples were centrifuged at 1200g for 15 min at 4°C, and the radioactivity in the bound fractions was counted in a gamma counter (1261 Multigamma; Wallac) for 5 min.
The extracted values were all corrected for recovery.
To measure aldosterone by a direct method, we used a Coat-A-Count kit (DPL Division, Euro/DPC), according to the manufacturer's instruction. Plasma (200 L) was placed into antibody-coated tubes, to which was then added 1 mL of 125 I-labeled aldosterone. The samples were mixed and incubated at 37°C for 3 h before being decanted and counted for radioactivity in the gamma counter for 1 min. A 7-point calibration curve was constructed from the reconstituted calibrators provided with the kit (0 to 3300 pmol/L) and treated similarly. The
